Select Language
Free Registration
My Cart

HLA-A*0201 & B2M & KRAS (KLVVVGAGGV)

HLA-A*0201 & B2M & KRAS (KLVVVGAGGV) Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    His Tag & Avi Tag (1)

  • Conjugate

    Biotin-labeled (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeatureOrder Now
HLS-H82E4
Human
HEK293
Biotinylated Human HLA-A*02:01&B2M&KRAS (KLVVVGAGGV) Complex Protein (Monomer, MALS verified) Add to Cart
Total: 1
  • 1

HLA-A*0201 & B2M & KRAS (KLVVVGAGGV) Background

The Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) oncogene plays a critical role in the initiation and maintenance of pancreatic tumors and its signaling network represents a major target for therapeutic intervention. The Human HLA-A*0201 KRAS (KLVVVGAGGV) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M, and KLVVVGAGGV peptide of the KRAS.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
IMVT-1402HL-161 ANS; IMVT-1402Phase 2 ClinicalImmunovant Sciences Gmbh, HanAll Biopharma Co LtdAutoimmune Diseases; Graves Disease
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
Efgartigimod alfaARGX-113; EFG PH20; EFG PH20 SC; PH20 SC; ARGX-113-2308ApprovedArgenx SeVYVGART HYTRULO, VYVDURA, VYVGART, 卫伟迦United StatesMyasthenia GravisArgenx BV2021-12-17Graves Ophthalmopathy; Tachycardia; Pemphigus; Thrombocytopenia; Guillain-Barre Syndrome; Eye Diseases; Nephrotic Syndrome; Muscular Diseases; Pemphigoid, Bullous; Optic Neuritis; Glomerulonephritis, Membranous; Rejection of organ transplantation; Purpura, Thrombocytopenic, Idiopathic; Lupus Nephritis; Scleroderma, Systemic; Stiff-Person Syndrome; Sjogren's Syndrome; Postural Orthostatic Tachycardia Syndrome; Polyneuropathies; Myositis; Nephrosis; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Myasthenia Gravis
Details
RozanolixizumabUCB-7665ApprovedUcb SaRYSTIGGOUnited StatesMyasthenia GravisUcb Inc2023-06-27Myasthenia Gravis; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Purpura, Thrombocytopenic, Idiopathic; Encephalitis; Fibromyalgia
Details
Efgartigimod alfa/HyaluronidaseApprovedArgenx BVVYVDURA, VYVGART HYTRULOUnited StatesMyasthenia GravisArgenx BV2023-06-20Myasthenia Gravis
Details
  • Product List
  • Marketed Drug Information
  • Clinical Drug Information
Share to:

Join UsLegalSite MapPrivacy PolicyTerms and Conditions
Website Feedback
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

order@acrobiosystems.com

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland